Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
about
Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological TheoryAnti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding siteExploring peptide mimics for the production of antibodies against discontinuous protein epitopes.Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchangeRequirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.Phages and HIV-1: from display to interplay.Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapyArchitectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesStructure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies.Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine DesignThe membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine designBroadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities.An engineered CX3CR1 antagonist endowed with anti-inflammatory activity.
P2860
Q28071559-8BB39374-8C19-45CE-90AE-3D2494BF35EFQ33377024-5D3F5B7F-6267-41DD-93CC-23C2857EB5F0Q33520582-F2801751-343D-4162-84A9-7FCB825F365AQ34055984-946A9021-03A4-4A55-85B2-021081245668Q34225659-789C64A8-7E29-47DB-9CB8-078EE2FB11F6Q34273397-5B3BFF71-A75C-40BB-B7DC-3518F5396607Q34700019-88541A32-9AFC-4230-9137-E9A5DFD2B1B4Q34774808-DC0F953D-5FF8-4040-AB86-69A661C6141AQ36016347-4E49A2B4-1235-4A7E-B5C9-B6DA1407B0EEQ36059926-9AFBB8D2-FFA1-404E-9AC3-EF95A2590B30Q36447540-3E5042D7-CAC6-4595-A62F-DA0ACBDAB821Q36497712-FB906AAA-962E-4F59-9C31-66BAA5CFBAC2Q38695294-0A2E5B44-D486-41EB-BE66-191B372D3717Q51778397-76104564-5B3B-45C0-AD3E-549729D5ABD3
P2860
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
@ast
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
@en
type
label
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
@ast
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
@en
prefLabel
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
@ast
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
@en
P2093
P356
P1476
Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
@en
P2093
Christophe Parizot
Guy Gorochov
Ismaïl Dogan
Karim Dorgham
Natacha Bitton
Oliver Hartley
Valerie Cardona
P356
10.1089/AID.2005.21.82
P577
2005-01-01T00:00:00Z